Antibody drug lowers risk of death in elderly coronavirus patients: Study1 min read . Updated: 31 Jul 2020, 07:33 AM IST
- Biocon Ltd received regulatory approval in India for itolizumab for use in coronavirus infected patients
- Researchers, which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented COVID-19 from worsening
An antibody drug already being used against the coronavirus in Cuba decreased the risk of intensive care admission and death among nursing home residents with moderate COVID-19, according to a small study conducted in the island nation.
Select your Category